| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CohBar, Inc. | Chief Scientific Officer | Common Stock | 10,000 | $7,300 | $0.7300 | 11 Aug 2021 | Direct |
| CohBar, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 750,000 | 11 Aug 2021 | Direct | ||
| Anebulo Pharmaceuticals, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 115,037 | 04 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. | 04 Apr 2025 | 1 | $0 | 4 | Chief Scientific Officer | 07 Apr 2025, 21:41 |
| ANEB | Anebulo Pharmaceuticals, Inc. | 29 Feb 2024 | 1 | $0 | 4/A | Chief Scientific Officer | 08 Mar 2024, 08:07 |
| ANEB | Anebulo Pharmaceuticals, Inc. | 29 Feb 2024 | 1 | $0 | 4 | Chief Scientific Officer | 01 Mar 2024, 18:24 |
| ANEB | Anebulo Pharmaceuticals, Inc. | 09 Dec 2022 | 1 | $0 | 4 | Chief Scientific Officer | 13 Dec 2022, 20:19 |
| ANEB | Anebulo Pharmaceuticals, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Chief Scientific Officer | 07 Jun 2022, 16:10 |
| ANEB | Anebulo Pharmaceuticals, Inc. | 20 May 2022 | 0 | $0 | 3 | Chief Scientific Officer | 24 May 2022, 16:34 |
| CWBR | CohBar, Inc. | 11 Aug 2021 | 3 | -$12,800 | 4 | Chief Scientific Officer | 13 Aug 2021, 16:02 |